(EMAILWIRE.COM, October 17, 2019 ) The global Cellular Health Screening market is segmented on the basis of type, collection site, and region. Factors such as the increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market.

Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. In 2017, the single test panels segment is expected to account for the largest share of the global cellular health screening market. These panels are used to get accurate information about a single biomarker and understand how it affects the health of an individual. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930

By sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. The at-home segment is expected to register the highest CAGR during the forecast period. The availability of diagnostic and therapeutic products that can be used by patients at home without assistance from healthcare professionals are expected to boost the demand for cellular health screening in this segment.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=227041930

In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region. In 2017, Europe is expected to hold the second largest share of this market. Factors such as increasing burden of chronic diseases and initiatives to create awareness about cellular biomarkers are expected to fuel the market growth in this region.

The major players operating in this market are Genova Diagnostics (U.S.), Telomere Diagnostics (U.S.), Life Length (Spain), Quest Diagnostics (U.S.), Repeat Diagnostics (Canada), SpectraCell Laboratories (U.S.), Zimetry LLC (U.S.), Cell Science Systems (U.S.), Titanovo, Inc. (U.S.), Segterra, Inc. (U.S.), LabCorp Holdings (U.S.), BioReference Laboratories (U.S.), Immundiagnostik AG (Germany), DNA Labs (India), and Cleveland HeartLab, Inc. (U.S.).

Read More@
https://www.marketsandmarkets.com/PressReleases/cellular-health-screening-test.asp